Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Slifstein

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Biological Psychiatry|April 9, 2016
Mechanisms of Working Memory Impairment in SchizophreniaJared X Van Snellenberg, Ragy R Girgis, Guillermo Horga, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2025
EC<sub>50</sub> images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studiesAlaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, et al.
Biological Psychiatry|July 6, 2010
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonistGraham Searle, John D Beaver, Robert A Comley, et al.
The American Journal of Psychiatry|December 7, 2005
Altered prefrontal dopaminergic function in chronic recreational ketamine usersRajesh Narendran, W Gordon Frankle, Richard Keefe, et al.
Biological Psychiatry|September 17, 2013
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyDiana Martinez, Mark Slifstein, Nabeel Nabulsi, et al.
Molecular Imaging and Biology|August 24, 2010
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PETSantiago Bullich, Mark Slifstein, Jan Passchier, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Neuroinflammation in World Trade Center responders at midlife: A pilot study using [<sup>18</sup>F]-FEPPA PET imagingYael Deri, Sean A P Clouston, Christine DeLorenzo, et al.
Psychopharmacology|August 16, 2016
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNORagy R Girgis, Mark Slifstein, Deepak D'Souza, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomographyRobert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Schizophrenia (Heidelberg, Germany)|February 26, 2022
Deep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: Proof-of-concept studyScott J Moeller, Roberto Gil, Jodi J Weinstein, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Biological Psychiatry|April 9, 2016
Mechanisms of Working Memory Impairment in SchizophreniaJared X Van Snellenberg, Ragy R Girgis, Guillermo Horga, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2025
EC<sub>50</sub> images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studiesAlaaddin Ibrahimy, Su Jin Kim, Mark E Schmidt, et al.
Biological Psychiatry|July 6, 2010
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonistGraham Searle, John D Beaver, Robert A Comley, et al.
The American Journal of Psychiatry|December 7, 2005
Altered prefrontal dopaminergic function in chronic recreational ketamine usersRajesh Narendran, W Gordon Frankle, Richard Keefe, et al.
Biological Psychiatry|September 17, 2013
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyDiana Martinez, Mark Slifstein, Nabeel Nabulsi, et al.
Molecular Imaging and Biology|August 24, 2010
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PETSantiago Bullich, Mark Slifstein, Jan Passchier, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Neuroinflammation in World Trade Center responders at midlife: A pilot study using [<sup>18</sup>F]-FEPPA PET imagingYael Deri, Sean A P Clouston, Christine DeLorenzo, et al.
Psychopharmacology|August 16, 2016
Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNORagy R Girgis, Mark Slifstein, Deepak D'Souza, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomographyRobert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Schizophrenia (Heidelberg, Germany)|February 26, 2022
Deep rTMS of the insula and prefrontal cortex in smokers with schizophrenia: Proof-of-concept studyScott J Moeller, Roberto Gil, Jodi J Weinstein, et al.
Pageof 14